Spectral AI Inc (MDAI) reports significant growth in research and development revenue, strategic deployments, and plans for FDA submission, while navigating commercial readiness challenges.
DALLAS, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for ...
--Spectral AI, Inc., an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its intent to spin off its ...
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving ...
Operator: Good day, and welcome to the Spectral AI First Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. - Part 4 ...
Spectral AI, Inc. is a predictive artificial intelligence company. It focuses on medical diagnostics for accurate treatment decisions in wound care for burn, DFU, and future clinical applications ...
DALLAS, April 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for ...
Spectral AI, Inc. 競合他社・同業他社分析 - Industrial Applications and Services セクター
Our AI model demonstrates 29% historical accuracy for MDAI predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
VAR_0__株価予測に影響を与える要因は何か?
当社の分析では、Spectral AI, Inc.の財務指標、Industrial Applications and Servicesセクターの動向、市場センチメント、テクニカル指標、業績データ、株価に影響を与えるマクロ経済要因を考慮しています。